2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Abstract Number: 2249

Risk and Risk Perception of Knee Osteoarthritis in the US: Population-Based Study
Abstract Number: 2250

The Relationship Between Sex and Incident Knee Osteoarthritis Is Mediated By Shape
Abstract Number: 2251

Current Tobacco Use and the Rates of Postoperative Complications after Total Knee Arthroplasty
Abstract Number: 2252

Declining Post-Arthroplasty Mortality after Total Knee Arthroplasty in the U.S.: A Time-Trends Study
Abstract Number: 2253

Racial Disparities in Total Shoulder Arthroplasty Utilization and Outcomes Are Persisting
Abstract Number: 2254

Socio-Economically Deprived Patients Have a Higher Likelihood for Having Any Type of Rheumatic and Musculoskeletal Diseases and Have Higher Healthcare Costs – Results from a Population-Based Administrative Database Including 1.9 Million Persons (Basque country, Spain)
Abstract Number: 2255

Capillaroscopic Patterns in a Healthy Population
Abstract Number: 2256

Clinical Characteristics, Laboratory Findings and Nailfold Capillaroscopy Microscopy Patterns in a Monocentric Series of 123 Patients with Idiopathic Pernio
Abstract Number: 2257

Decline of Lung Function Is Associated with the Presence of Rheumatoid Factor in Korean Health Screening Subjects without Clinically Apparent Lung Diseases
Abstract Number: 2259

Incidence of Obesity, Diabetes and High Blood Pressure Associated with Arthritis: Analysis of the Canadian Longitudinal National Population Health Survey
Abstract Number: 2260

High Prevalence of Hypomagnesemia and Its Relation to BMI, Type 2 Diabetes, and Clinical Disease Measures in a VA Outpatient Rheumatology Clinic Population
Abstract Number: 2261

Association Between Musculoskeletal Pain, Fat Mass and Fat Free Mass: Results from a Population-Based Study
Abstract Number: 2262

A Novel Study Instrument to Identify Household Work Related Musculoskeletal Disorders – Development and Validation
Abstract Number: 2263

Construct and Convergent Validity of Four Global Measures of at-Work Productivity Loss in Patients with Rheumatic Diseases
Abstract Number: 2264

Prevalence and Social Burden of Active Chronic Low Back Pain in the Adult Portuguese Population – Results from a National Survey

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].